​

Taysha Gene Therapies (TSHA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Taysha Gene Therapies Revenue Highlights

Latest Revenue (Y)

$8.33M

Latest Revenue (Q)

$1.99M

Taysha Gene Therapies Revenue by Period

Taysha Gene Therapies Revenue by Year

DateRevenueChange
2024-12-31$8.33M-46.07%
2023-12-31$15.45M517.55%
2022-12-31$2.50M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Taysha Gene Therapies generated $8.33M in revenue during NA 2024, up -46.07% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Taysha Gene Therapies Revenue by Quarter

DateRevenueChange
2025-06-30$1.99M-13.73%
2025-03-31$2.30M13.85%
2024-12-31$2.02M13.09%
2024-09-30$1.79M60.79%
2024-06-30$1.11M-67.40%
2024-03-31$3.41M-5.36%
2023-12-31$3.60M-24.06%
2023-09-30$4.75M98.16%
2023-06-30$2.40M-49.11%
2023-03-31$4.71M88.09%
2022-12-31$2.50M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31--

Taysha Gene Therapies generated $1.99M in revenue during Q2 2025, up -13.73% compared to the previous quarter, and up 58.22% compared to the same period a year ago.

Taysha Gene Therapies Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARDXArdelyx$333.62M$97.66M
MAZEMaze Therapeutics$167.50M-
WVEWave Life Sciences$108.30M$8.70M
IMTXImmatics$54.00M$30.45M
IMNMImmunome$9.04M$2.93M
TSHATaysha Gene Therapies$8.33M$1.99M
NUVBNuvation Bio$7.87M$4.83M
ATAIAtai Life Sciences-$1.55M
ELVNEnliven Therapeutics--
SYRESpyre Therapeutics--
TRMLTourmaline Bio--

TSHA Revenue FAQ

What is Taysha Gene Therapies’s yearly revenue?

Taysha Gene Therapies's yearly revenue for 2024 was $8.33M, representing a decrease of -46.07% compared to 2023. The company's yearly revenue for 2023 was $15.45M, representing an increase of 517.55% compared to 2022. TSHA's yearly revenue for 2022 was $2.5M, representing an increase of 100.00% compared to 2021.

What is Taysha Gene Therapies’s quarterly revenue?

Taysha Gene Therapies's quarterly revenue for Q2 2025 was $1.99M, a -13.73% decrease from the previous quarter (Q1 2025), and a 78.60% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $2.3M, a 13.85% increase from the previous quarter (Q4 2024), and a -32.51% decrease year-over-year (Q1 2024). TSHA's quarterly revenue for Q4 2024 was $2.02M, a 13.09% increase from the previous quarter (Q3 2024), and a -43.90% decrease year-over-year (Q4 2023).

What is Taysha Gene Therapies’s revenue growth rate?

Taysha Gene Therapies's revenue growth rate for the last 3 years (2022-2024) was 233.05%, and for the last 5 years (2020-2024) was 0%.